ENDRA Life Sciences (NDRA) Shares Outstanding (2016 - 2026)

ENDRA Life Sciences (NDRA) has reported Shares Outstanding (Entity) for 11 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 99.34% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $1.5 million, a 99.34% increase from a year earlier, with the FY2025 full-year figure at $787020.0, up 289.41% from the prior year.
• Shares Outstanding (Entity) was $1.5 million for Q2 2026 at ENDRA Life Sciences, up from $1.2 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $1.5 million in Q2 2026 and troughed at $43054.0 in Q1 2022.
• A 5-year average of $419643.7 and a median of $210197.5 in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) climbed 3.46% in 2022 and surged 355.0% in 2024, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $63382.0 in 2022, then jumped by 100.81% to $127275.0 in 2023, then surged by 58.79% to $202106.0 in 2024, then jumped by 289.41% to $787020.0 in 2025, then jumped by 90.57% to $1.5 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $1.5 million (Q2 2026), $1.2 million (Q1 2026), and $787020.0 (Q4 2025), per Business Quant data.